Results 151 to 160 of about 12,554 (221)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis. [PDF]

open access: yesNPJ Vaccines, 2019
Boehm DT   +14 more
europepmc   +1 more source

A model based evaluation of the 1996-7 pertussis epidemic in the Netherlands [PDF]

open access: yes, 2001
Boven, M., van   +3 more
core   +2 more sources

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

open access: yesLancet Glob Health
Nakabembe E   +22 more
europepmc   +1 more source

Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.

open access: yesJAMA Pediatr, 2018
Wood N   +6 more
europepmc   +1 more source

Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women. [PDF]

open access: yesVaccine, 2018
Fortner KB   +11 more
europepmc   +1 more source

Diphtheria and pertussis outbreaks in the Americas: a scoping review of epidemiology, vaccination trends and control strategies, 2013-2024. [PDF]

open access: yesBMJ Public Health
Jean Baptiste AE   +6 more
europepmc   +1 more source

Pathogenicity and vaccine protection of circulating pertactin- and filamentous hemagglutinin-deficient <i>Bordetella pertussis</i> strains. [PDF]

open access: yesEmerg Microbes Infect
Dai H   +16 more
europepmc   +1 more source

Seroprevalence of diphtheria, tetanus, pertussis among healthcare workers (HCWs) - A cross-sectional study at the National Centre for Infectious Diseases and Tan Tock Seng Hospital, Singapore. [PDF]

open access: yesHum Vaccin Immunother
Lim DW   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy